Ziritaxestat
Ziritaxestat (GLPG1690), an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in idiopathic pulmonary fibrosis patients.
| Catalog Number | T4041 |
| Alternative Name(s) | GLPG1690 |
| Research Area | Metabolism |
| Molecular Formula | C30H33FN8O2S |
| CAS# | 1628260-79-6 |
| Purity | 99.67% |
| SMILES | CCc1nc2c(C)cc(cn2c1N(C)c1nc(c(s1)C#N)-c1ccc(F)cc1)N1CCN(CC(=O)N2CC(O)C2)CC1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Ziritaxestat |
| Additional Information | https://www.targetmol.com/datasheet/T4041 |